| Ghislaine Robert, MD | |
|
8630 164th Ave Ne, 205, Redmond, WA 98052-3606 | |
| (425) 836-1800 | |
| (425) 836-1877 |
| Full Name | Ghislaine Robert |
|---|---|
| Gender | Female |
| Speciality | Orthopedic Surgery |
| Experience | 42 Years |
| Location | 8630 164th Ave Ne, Redmond, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679598510 | NPI | - | NPPES |
| 5576RO | Other | WA | BLUE SHIELD |
| 0039594 | Other | WA | LABOR & INDUSTRY |
| 8390775 | Medicaid | WA | |
| US7933591 | Other | WA | AETNA/USHC SPECIALIST |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2081S0010X | Physical Medicine & Rehabilitation - Sports Medicine | MD00042487 (Washington) | Primary |
| Entity Name | Docteure Ghislaine Robert Md Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629462494 PECOS PAC ID: 3870813231 Enrollment ID: O20150526002490 |
News Archive
The pharmaceutical company Merck on Monday named former CDC head Julie Gerberding as president of the company's vaccine division, Reuters reports. "Gerberding, who led the CDC from 2002 to 2009 and stepped down when President Barack Obama took office, will head up the company's $5 billion global vaccine business that includes shots to prevent chickenpox, cervical cancer and pneumonia," the news service reports.
Researchers have closed a randomized clinical trial comparing gefitinib (Iressa) vs. placebo following chemotherapy and radiation for patients with non-small cell lung cancer (NSCLC) that had spread only to nearby tissues or lymph nodes. Review of interim data indicated that gefitinib would not improve survival.
Researchers at the University of California, San Diego School of Medicine have identified the molecular mechanism that makes omega-3 fatty acids so effective in reducing chronic inflammation and insulin resistance.
Four health insurers led by Cigna Corp. have asked the Obama administration to exempt medical plans they sell to Americans overseas from the 2010 health law, saying a denial may imperil about 1,100 U.S. jobs.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ghislaine Robert, MD 8630 164th Ave Ne, 205, Redmond, WA 98052-3606 Ph: (425) 836-1800 | Ghislaine Robert, MD 8630 164th Ave Ne, 205, Redmond, WA 98052-3606 Ph: (425) 836-1800 |
News Archive
The pharmaceutical company Merck on Monday named former CDC head Julie Gerberding as president of the company's vaccine division, Reuters reports. "Gerberding, who led the CDC from 2002 to 2009 and stepped down when President Barack Obama took office, will head up the company's $5 billion global vaccine business that includes shots to prevent chickenpox, cervical cancer and pneumonia," the news service reports.
Researchers have closed a randomized clinical trial comparing gefitinib (Iressa) vs. placebo following chemotherapy and radiation for patients with non-small cell lung cancer (NSCLC) that had spread only to nearby tissues or lymph nodes. Review of interim data indicated that gefitinib would not improve survival.
Researchers at the University of California, San Diego School of Medicine have identified the molecular mechanism that makes omega-3 fatty acids so effective in reducing chronic inflammation and insulin resistance.
Four health insurers led by Cigna Corp. have asked the Obama administration to exempt medical plans they sell to Americans overseas from the 2010 health law, saying a denial may imperil about 1,100 U.S. jobs.
› Verified 2 days ago
Susan D Mcginnis, P.T. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 2700 152nd Ave Ne, Redmond, WA 98052 Phone: 425-883-5151 |